Seeking Alpha

Dan Jacome » Comments » AGN

  • Johnson & Johnson Steals Mentor Corp.: Who's Next? [View article]
    Good article on Botox claims in the recession here

    online.wsj.com/article...
    Dec 22 23:11 pm |Rating: 0 0 |Link to Comment
  • Johnson & Johnson Steals Mentor Corp.: Who's Next? [View article]
    "extreme distress" on AGN is an exagerrated claim - they have the eye care business, c'mon!
    Dec 12 11:11 am |Rating: 0 0 |Link to Comment
  • Johnson & Johnson Steals Mentor Corp.: Who's Next? [View article]
    Dannyboy,

    GILD is certainly one of the more attractive franchises out there - we've heard a lot of rumor concerning a potential MRK/GILD combination in 2009, but at this point, its a lot more rumor than cold fact.
    Dec 08 15:49 pm |Rating: 0 0 |Link to Comment
  • Johnson & Johnson Steals Mentor Corp.: Who's Next? [View article]
    ENuff,

    thanks for compliment - yes, JNJ going for AGN could also work, although a stretch since JNJ just came off 2 deals. Having a Botox product to supplement its new Mentor-based implant business would be awesome, but wouldnt that negate the work MNT is doing now with Purtox?

    Funny thing is, this whole deal is JNJs way of getting back @ AGN for the latter grabbing Inamed off the market years ago
    Dec 08 12:36 pm |Rating: 0 0 |Link to Comment
  • Cramer's Mad Money - Will Pfizer Buy Allergan? (12/3/08) [View article]
    He has a great point with PFE needing to do a deal, although, he forgets to mention how much competitive pressure Botox may come under over the next 2-3 years. Its eye care business is half if its sales and that part of the company seems better "protected" from competition.

    Medicis is a company that will most likely get picked off before Allergan does. The price tag would be < $1B and the suitor would get the #1 dermal filler player in the country (which will also benefit from Baby Boomers entering peak years - fillers target older people, Botox typically people under 50) and access to a top acne drug - Solodyn - which wont go generic probably until 2011 or at the latest, 2013.
    Dec 08 00:16 am |Rating: 0 0 |Link to Comment
  • Credit Suisse Healthier 15: Investors Get the Skinny on Fat Fighters [View article]
    DKS has been a terrible investment for us, the St tested $30 level 3 times and then the stock snapped like a breadstick...
    Jun 28 18:21 pm |Rating: 0 0 |Link to Comment
More on AGN by Dan Jacome
Comments by Ticker
AA, AAPL, ABC, ABMD, ABT, ABWTQ.PK, ABX, ACAD, ACHN, ACI, ACLS, ACMR, ACN, ACS, ACXM, ADBL, ADCT, ADLR, ADM, ADP, ADSK, ADY, AEM, AEO, AET, AFAM, AFFM, AFFX, AFL, AGN, AGU, AHBIF.PK, AHL, AIB, AIG, AINV, AIXG, AKAM, AKS, ALB, ALD, ALGT, ALKS, ALL, ALO, ALU, ALVR, AMAG, AMAT, AMD,
Dan Jacome's
Comments Stats
683 comments
Rating: 67 (91 - 24 )